Profile
Gwendolyn Fisher is currently a Director at Palm Beach Civic Association.
Previously, she was a Vice President-Corporate Communications at Amarin Corp.
Plc from 2019 to 2020, and a Head-Communications & Public Affairs at Shire Plc from 1920 to 2016.
She also served as a Vice President-Corporate Communications at Passage Bio, Inc. from 2020 to 2022.
Fisher holds an MBA degree from UCLA Anderson School of Management.
Gwendolyn Fisher active positions
| Companies | Position | Start |
|---|---|---|
Palm Beach Civic Association
Palm Beach Civic Association Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization to protect and improve palm beach | Director/Board Member | - |
Former positions of Gwendolyn Fisher
| Companies | Position | End |
|---|---|---|
| PASSAGE BIO, INC. | Public Communications Contact | 01/03/2022 |
| AMARIN CORPORATION PLC | Public Communications Contact | 01/01/2020 |
| SHIRE | Public Communications Contact | 01/06/2016 |
Training of Gwendolyn Fisher
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Palm Beach Civic Association
Palm Beach Civic Association Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization to protect and improve palm beach | Commercial Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Gwendolyn Fisher
















